Global Life Sciences

News & Analysis
- - - Categories
    - News & Analysis
    - Long Reads
    - Opinion
  - - Topics
    - Copyright, designs & trademarks
    - Finance & valuation
    - FRAND/SEPs
    - Law & policy
    - Licensing
    - Litigation
    - Trade secrets
    - Transactions
  - - Regions
    - Africa & Middle East
    - Asia-Pacific
    - Europe
    - Latin America & Caribbean
    - North America
Reports
- - - Reports
    - Special Reports
    - Panel Reports
    - Reports Centre
Data & Tools
- - - Data
    - Patent 1000 Analytics
    - Data Analysis
    - Data Hub
  - - Tools
    - GTDT
Rankings
- - - IAM Patent 1000
    - Introduction
    - All Firms
    - All Individuals
  - - IAM Strategy 300
    - Introduction
    - All individuals
  - - Global Leaders
    - IAM Global Leaders
    - Strategy 300 Global Leaders
  - - IAM Analytics
    - Patent 1000 Analytics
Insight
- - - Insight
    - Guides
    - Regional Reviews
    - Market Insight
  - - Hub
    - SEP/FRAND
Events
- - - Events
    - IAM & IPBC events
    - Diary
IAM Market
- Visit WTR
- About
- Archive
Login | Register
Subscribe Now

Home
Guides
IAM Life Sciences: Key issues for senior life sciences executives 2019

IAM Life Sciences: Key issues for senior life sciences executives 2019

The key IP issues that entities operating in the pharmaceutical and biotechnology industries may confront as they develop and roll out their business strategies.

Articles

Pharmaceutical inventions and patent term extension procedure

Elena Nazina
Gorodissky & Partners